What is the recommended dose of Auvelity (dextromethorphan/quinidine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Auvelity Dosing

Start with one tablet (45 mg dextromethorphan/105 mg bupropion) once daily in the morning for 3 days, then increase to one tablet twice daily (at least 8 hours apart) as the standard maintenance dose. 11

Standard Dosing Algorithm

Initial Phase (Days 1-3):

  • 1 tablet once daily in the morning
  • Take with or without food
  • Swallow whole—do not crush, divide, or chew

Maintenance Phase (Day 4 onwards):

  • 1 tablet twice daily
  • Minimum 8-hour interval between doses
  • Maximum: 2 tablets per 24 hours

Dose Modifications Required

You must reduce to one tablet once daily (morning only) in these specific situations:

Renal Impairment:

  • Moderate renal impairment (eGFR 30-59 mL/min/1.73 m²) 1

Drug Interactions:

  • Concomitant use with strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, quinidine) 1

Genetic Factors:

  • Known CYP2D6 poor metabolizers 1

Critical Pre-Treatment Requirements

Before prescribing, you must:

  • Assess and monitor blood pressure throughout treatment
  • Screen for bipolar disorder history (personal or family)
  • Verify no concurrent bupropion or dextromethorphan from other sources 11

MAOI Washout Period

14-day washout required in both directions:

  • Stop MAOI → wait 14 days → start Auvelity
  • Stop Auvelity → wait 14 days → start MAOI 1

Common Pitfalls to Avoid

  • Do not exceed 2 tablets daily regardless of response
  • Do not split or crush tablets—this destroys the extended-release formulation
  • Do not use in patients with seizure disorders, eating disorders, or those abruptly discontinuing alcohol/benzodiazepines—these are absolute contraindications 1
  • Monitor for activation/mania given the bupropion component 1

The evidence shows rapid onset of antidepressant effects within 2 weeks 2, with this fixed-dose combination approved specifically for major depressive disorder in adults 1. The dosing is straightforward with limited titration compared to most antidepressants, though the twice-daily regimen requires patient adherence to the 8-hour spacing.

References

Research

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.